Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma

Background: The aim of this study was to evaluate real-world clinical outcomes and transplant-related complications of allogeneic stem cell transplantation (alloSCT) for Hodgkin lymphoma (HL). Methods: This was a single-centre, retrospective analysis of relapsed and refractory (R/R) HL patients who...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Shiliang Ge, Kylie Lepic, Ravi Bhindi, Tobias Berg, Dina Khalaf, Brian Leber, Michael Radford, Irwin Walker, Gwynivere Davies, Alejandro Garcia-Horton
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Subjects:	Hodgkin lymphoma allogeneic stem cell transplant relapse refractory PD-1 inhibitor
Online Access:	https://www.mdpi.com/1718-7729/32/2/118